Infection Risk During Targeted and Biologic Therapies in Rheumatoid Arthritis and Psoriatic Arthritis
An overview of the risk for infections during targeted and biologic therapies in rheumatoid arthritis and psoriatic arthritis.
Home
Examining Hospitalization, Mortality Trends Among Adult Patients With Systemic Lupus Erythematosus
Study authors analyzed all indications for adult systemic lupus erythematosus hospitalizations and reasons for in-hospital mortality.
Altered Pain Perception and Sensitivity Observed in Patients With Juvenile Idiopathic Arthritis
Researchers assessed pain perception and sensitivity, and self-reported pain in young adults with long-standing juvenile idiopathic arthritis.
Pulmonary Function Tests May Underdiagnose Interstitial Lung Disease in Juvenile Systemic Sclerosis
Study authors determined the performance of pulmonary screening vs HRCT in detecting interstitial lung disease in juvenile SSc.
Methotrexate Injection Now Available for Rheumatoid Arthritis, Juvenile Idiopathic Arthritis
RediTrex is approved for rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, and psoriasis.
Expertscape Publishes Top 10 Specialists in Rheumatoid Arthritis
Expertscape, a web platform that uses the PubMed database and its patented algorithm to identify and objectively rank physicians and researchers that excel in the treatment and diagnosis of specific disease states, has released their rankings for U.S. physicians who specialize in the research and treatment of rheumatoid arthritis. Using Expertscape’s rigorous process, Roy Fleischman,…
Gastrointestinal Transit Abnormalities Associated With Severe GI Symptoms in Scleroderma
Researchers evaluated the contribution of abnormal GI transit to systemic sclerosis Medsger GI severity scores and/or UCLA GIT 2.0 symptoms.
Osteoarthritis, NSAID Allergy Are Risk Factors for Opioid Use Disorder
Researchers assessed whether patients with osteoarthritis and NSAID allergies have higher odds of developing opioid use disorder, and identified next steps to be considered for this patient population.
No Increased Cardiovascular Risk With Febuxostat vs Allopurinol in Gout
In contrast to CARES, FAST found that treatment with febuxostat was not associated with an increase in cardiovascular or all-cause death compared with allopurinol in patients with gout.
Evidence Lacking for Most Fibromyalgia Therapies
To assess the effectiveness of these therapies on pain reduction and quality of life improvement, study authors searched various databases for randomized or quasi-randomized clinical trials that evaluated these outcomes in fibromyalgia patients.
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Fibromyalgia
